Johnson & Johnson's Coronavirus Vaccine Won't Be in Clinical Trials Until November
The little guys are winning the race to develop the first vaccine against the SARS-CoV-2 coronavirus that causes COVID-19.
Moderna (NASDAQ: MRNA) started a phase 1 clinical trial for its coronavirus vaccine mRNA-1273 this week. Earlier this month, Inovio Pharmaceuticals (NASDAQ: INO) said it's finishing up preclinical testing of its INO-4800 vaccine and plans to start a clinical trial next month.
Big old Johnson & Johnson (NYSE: JNJ)? The healthcare conglomerate doesn't even have a candidate yet.
Source Fool.com
